Susana Pedrinaci

1.1k total citations
24 papers, 580 citations indexed

About

Susana Pedrinaci is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Susana Pedrinaci has authored 24 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 8 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Susana Pedrinaci's work include Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Susana Pedrinaci is often cited by papers focused on Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Susana Pedrinaci collaborates with scholars based in Spain, United States and Germany. Susana Pedrinaci's co-authors include Federico Garrido, Francisco Ruiz‐Cabello, Pilar Jiménez, Rosa Méndez, Daniel E. Geraghty, Ángel M. García‐Lora, José Manuel Cózar, Teresa Cabrera, M Tallada and José María Romero and has published in prestigious journals such as Annals of Neurology, International Journal of Cancer and British Journal of Haematology.

In The Last Decade

Susana Pedrinaci

22 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susana Pedrinaci Spain 12 423 190 123 36 35 24 580
Wanhu Tang United States 12 356 0.8× 81 0.4× 134 1.1× 31 0.9× 27 0.8× 21 541
Stephanie L. Kelich United States 8 272 0.6× 122 0.6× 207 1.7× 31 0.9× 47 1.3× 10 561
Tzong-Shyuan Tai Taiwan 11 324 0.8× 130 0.7× 216 1.8× 57 1.6× 48 1.4× 21 616
Amy L. Rymaszewski United States 9 284 0.7× 97 0.5× 202 1.6× 19 0.5× 33 0.9× 9 493
M. Hagenhofer Germany 6 663 1.6× 51 0.3× 234 1.9× 20 0.6× 49 1.4× 7 834
Dong U. Lee United States 9 722 1.7× 130 0.7× 425 3.5× 28 0.8× 68 1.9× 9 1.0k
Elisaveta Voynova United States 16 450 1.1× 70 0.4× 135 1.1× 21 0.6× 52 1.5× 23 643
K. K. Berry United States 9 247 0.6× 144 0.8× 295 2.4× 32 0.9× 37 1.1× 16 561
K Völker United States 10 226 0.5× 160 0.8× 193 1.6× 22 0.6× 36 1.0× 12 456
Chiori Shimizu Japan 12 684 1.6× 211 1.1× 278 2.3× 35 1.0× 52 1.5× 14 919

Countries citing papers authored by Susana Pedrinaci

Since Specialization
Citations

This map shows the geographic impact of Susana Pedrinaci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susana Pedrinaci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susana Pedrinaci more than expected).

Fields of papers citing papers by Susana Pedrinaci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susana Pedrinaci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susana Pedrinaci. The network helps show where Susana Pedrinaci may publish in the future.

Co-authorship network of co-authors of Susana Pedrinaci

This figure shows the co-authorship network connecting the top 25 collaborators of Susana Pedrinaci. A scholar is included among the top collaborators of Susana Pedrinaci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susana Pedrinaci. Susana Pedrinaci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blanco, Patricia, et al.. (2023). Severe congenital X-linked myopathy with excessive autophagy secondary to an apparently synonymous but pathogenic novel variant. Neuromuscular Disorders. 33(7). 557–561. 3 indexed citations
2.
Garrido-Navas, M. Carmen, et al.. (2022). Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective. Molecular Genetics and Genomics. 297(3). 859–871. 3 indexed citations
3.
Galán, José Jorge, Susana Pedrinaci, A. González, et al.. (2008). Identification of a 2244 base pair interstitial deletion within the human ESR1 gene in the Spanish population. Journal of Medical Genetics. 45(7). 420–424. 6 indexed citations
4.
Méndez, Rosa, Teresa Rodríguez, Isabel Maleno, et al.. (2007). Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines. Cancer Immunology Immunotherapy. 57(5). 719–729. 35 indexed citations
5.
6.
7.
Romero, José María, Pilar Jiménez, Teresa Cabrera, et al.. (2004). Coordinated downregulation of the antigen presentation machinery and HLA class I/β2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer. International Journal of Cancer. 113(4). 605–610. 114 indexed citations
8.
Rodríguez‐Revenga, Laia, Célia Bádenas, Aurora Sánchez, et al.. (2003). Cryptic chromosomal rearrangement screening in 30 patients with mental retardation and dysmorphic features. Clinical Genetics. 65(1). 17–23. 18 indexed citations
9.
García‐Lora, Ángel M., et al.. (2003). Different regulation of PKC isoenzymes and MAPK by PSK and IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line. Cancer Immunology Immunotherapy. 52(1). 59–64. 33 indexed citations
10.
Ruiz‐Cabello, Francisco, Susana Pedrinaci, Rosa Méndez, et al.. (2003). Analysis of HLA-E expression in human tumors. Immunogenetics. 54(11). 767–775. 135 indexed citations
11.
García‐Lora, Ángel M., Susana Pedrinaci, & Federico Garrido. (2001). Protein-bound polysaccharide K and interleukin-2 regulate different nuclear transcription factors in the NKL human natural killer cell line. Cancer Immunology Immunotherapy. 50(4). 191–198. 23 indexed citations
12.
Pedrinaci, Susana, Ángel M. García‐Lora, M. Pérez, et al.. (1999). Selective upregulation of MHC class I expression in metastatic colonies derived from tumor clones of a murine fibrosarcoma. International Journal of Clinical & Laboratory Research. 29(4). 166–173. 11 indexed citations
13.
Pedrinaci, Susana, Julie A. Hanson, & Chella S. David. (1994). Hierarchy in the assembly of HLA-B27 and HLA-Cw3 molecules in transgenic mice. Immunogenetics. 39(2). 130–7. 5 indexed citations
14.
Rodriguez, Moses, Susana Pedrinaci, & Chella S. David. (1993). Human class I major histocompatibility complex transgene prevents virus‐induced demyelination in susceptible mutant B 10.d2dml mice. Annals of Neurology. 33(2). 208–212. 12 indexed citations
15.
Collado, Antonia, et al.. (1991). Characterization of CD44 Antigen during Lymphoid Ontogeny. Immunobiology. 183(1-2). 1–11. 12 indexed citations
16.
Pedrinaci, Susana, et al.. (1990). Protein kinase C‐mediated regulation of the expression of CD14 and CD11 /CD18 in U937 cells. International Journal of Cancer. 45(2). 294–298. 28 indexed citations
17.
Esteban, Francisco, Ángel Concha, Millán Perez‐Ayala, et al.. (1989). Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx. International Journal of Cancer. 43(3). 436–442. 80 indexed citations
18.
González, Marcos, Susana Pedrinaci, Miguel Á. Piris, et al.. (1988). Distribution of the CD45R antigen in the maturation of lymphoid and myeloid series: the CD45R negative phenotype is a constant finding in T CD4 positive lymphoproliferative disorders. British Journal of Haematology. 69(2). 173–179. 25 indexed citations
19.
20.
Pedrinaci, Susana, et al.. (1987). Study of the monoclonal antibodies against blood group B and A + B (group 2) of the First international workshop. Pattern of reaction with colon carcinomas. Revue Franç aise de Transfusion et Immuno-hé matologie. 30(5). 609–611.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wanhu Tang Breakdown of academic impact, for papers by Stephanie L. Kelich Breakdown of academic impact, for papers by Tzong-Shyuan Tai Breakdown of academic impact, for papers by Amy L. Rymaszewski Breakdown of academic impact, for papers by M. Hagenhofer Breakdown of academic impact, for papers by Dong U. Lee Breakdown of academic impact, for papers by Elisaveta Voynova Breakdown of academic impact, for papers by K. K. Berry Breakdown of academic impact, for papers by K Völker Breakdown of academic impact, for papers by Chiori Shimizu
Rankless by CCL
2026